Abstract
To the Editor: The Dutch TIA Trial Study Group (Oct. 31 issue)1 has presented the results of a randomized, controlled study comparing the effects of two different doses of aspirin in patients with transient ischemic attacks or minor ischemic stroke. There was no significant difference in the occurrence of the combined end point of stroke, death from vascular causes, and acute myocardial infarction between the patients taking 30 mg of aspirin daily and those taking 283 mg. The authors concluded that the 30-mg dose was no less effective in preventing vascular events than the 283-mg dose. A problem with this.
Original language | English |
---|---|
Pages (from-to) | 1288-1289 |
Number of pages | 2 |
Journal | New England Journal of Medicine |
Volume | 326 |
Issue number | 19 |
DOIs | |
Publication status | Published - 7 May 1992 |